Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- GENERICS NEWS IN BRIEF
August 6, 2007
- Mitsubishi Tanabe to Start Domestic Sales with 15 Branches, 142 Business Offices
August 6, 2007
- Transnasal Endoscopy IT Forum to Start Full-Scale Activities
August 6, 2007
- NEW PRODUCTS／Flivas OD Tablet 75 mg: Asahi Kasei Pharma
August 6, 2007
- Incidence of Nasal Bleeding 6% in Transnasal Endoscopy
August 6, 2007
- Nippon Kayaku to Consolidate Its Position as Specialty Pharma Focusing on Oncology
August 6, 2007
- MEDICAL DEVICE NEWS IN BRIEF
August 6, 2007
- Astellas, Pfizer Initiate Campaign on Prevention of Arteriosclerosis
August 6, 2007
- Use IT to More Effectively Use Patients' Data: AstraZeneca President Dr Kato
August 6, 2007
- Pfizer Expanding Supply of Information on JZOLOFT to PCP
July 30, 2007
- Pacemakers Are Much Higher-Priced in Japan Than in South Korea, Thailand: Survey
July 30, 2007
- Janssen to Differentiate Risperdal from Generics
July 30, 2007
- Major Medical Systems Used for 10.3 Years
July 30, 2007
- Alfresa to Reduce SGA Expanses Ratio to Below 6% by FY2009
July 30, 2007
- MEDICAL DEVICE NEWS IN BRIEF
July 30, 2007
- BUSINESS NEWS IN BRIEF
July 30, 2007
- Benefits for OTC-Like Ethical Drugs to Be Reviewed in 4 to 5 Years
July 30, 2007
- 11 Generic Products (6 APIs) to Be Listed in November
July 30, 2007
- SELF-MEDICATION NEWS IN BRIEF
July 30, 2007
- NPhA to Further Promote Use of Generics
July 30, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…